Condition: Type 1 Diabetes · Child, Only · Sponsor: Sheba Medical Center
The goal of this observational study is to describe data on Israeli children and youth using the 780G system including data regarding glycemic control parameters, various questionnaires, sleep data, bioimpedance measures, and dietary parameters. The main questions it aims to answer are: • whether the 780G system will improve glycemic control • whether the psychosocial aspects will improve. Participants will be followed once connected to 780G, at baseline, one, three, six months, 1 year, and two years after the connection.
This description comes directly from the study's public registry record.
Noah Gruber, MD · +972507181666 · noah.gruber@sheba.health.gov.il
Elinor Mauda, BSc · +972543550783 · Elinor.Mauda@sheba.health.gov.il
Always discuss trial participation with your own doctor first.
| Sheba Medical Center | Ramat Gan, Please Select, Israel | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05908708